Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply
Lancet
.
2022 Mar 26;399(10331):1225.
doi: 10.1016/S0140-6736(22)00178-7.
Authors
Philip R Krause
1
,
Helen Rees
2
,
J Peter Figueroa
3
,
Soumya Swaminathan
4
,
Ana Maria Henao Restrepo
4
Affiliations
1
Bethesda, MD, 20817-4555, USA. Electronic address:
[email protected]
.
2
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
3
University of the West Indies, Mona, Jamaica.
4
World Health Organization, Geneva, Switzerland.
PMID:
35339221
PMCID:
PMC8947781
DOI:
10.1016/S0140-6736(22)00178-7
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Immunization, Secondary
Vaccines*
Substances
COVID-19 Vaccines
Vaccines
Grants and funding
001/WHO_/World Health Organization/International